Open-Angle Glaucoma: The Most Common Form Explained

One of the most challenging aspects of open-angle glaucoma is that it rarely produces warning signs until the disease has reached a moderate or advanced stage. This is why it is often called the 'silent thief of sight.'

Open-angle glaucoma typically damages the peripheral (side) vision first. Because people rely primarily on their central vision for reading, driving, and recognizing faces, early peripheral blind spots often go unnoticed. The loss develops so slowly that the brain adjusts to the shrinking visual field, making it difficult to detect changes through everyday experience alone.

The brain is remarkably good at filling in gaps in the visual field using information from the surrounding areas and the other eye. This compensatory mechanism means that a person can lose a significant amount of peripheral vision in one or both eyes without being aware of it. By the time symptoms become obvious, such as difficulty navigating stairs, bumping into objects, or trouble driving, a substantial portion of optic nerve fibers may already be irreversibly damaged.

Because you cannot feel elevated eye pressure and early vision loss is invisible to the patient, routine comprehensive eye exams are the only reliable way to catch open-angle glaucoma before it causes permanent harm. Our glaucoma specialists recommend that adults over 40, and those with risk factors at any age, undergo regular screening that includes pressure measurement and optic nerve evaluation.

Treatment focuses on lowering intraocular pressure to a level that slows or halts optic nerve damage. Most patients begin with prescription eye drops that either reduce fluid production or improve drainage. If drops are insufficient or poorly tolerated, laser procedures such as selective laser trabeculoplasty (SLT) offer a well-studied alternative. For more advanced cases, surgical options including minimally invasive glaucoma surgery (MIGS) or traditional filtration surgery may be recommended. Your treatment plan is tailored to your specific pressure target, disease stage, and overall health.

In open-angle glaucoma, the drainage angle remains structurally open but functions poorly, and the disease develops gradually over months to years. Angle-closure glaucoma occurs when the iris physically blocks the drainage angle, which can happen suddenly and cause a painful acute angle-closure attack with rapid vision loss, severe eye pain, and nausea. While open-angle glaucoma is far more common, angle-closure glaucoma is a medical emergency requiring immediate treatment.

There is currently no proven way to prevent open-angle glaucoma from developing. However, early detection through regular eye exams allows treatment to begin before noticeable vision loss occurs, which is the most effective strategy for preserving long-term sight. Maintaining a healthy lifestyle, protecting your eyes from injury, and informing your eye doctor about any family history of glaucoma all contribute to better outcomes.

In the early and moderate stages, most patients maintain excellent functional vision and can continue their normal activities without restriction. As the disease advances, peripheral vision loss may affect driving confidence, spatial awareness, and the ability to navigate unfamiliar environments. Many patients find that consistent use of prescribed treatments keeps the disease stable for decades, allowing them to maintain an active and independent lifestyle.

The most commonly prescribed first-line drops are prostaglandin analogs, such as latanoprost and bimatoprost, which increase fluid outflow through an alternative drainage pathway. Other medication classes include beta-blockers, alpha-adrenergic agonists, carbonic anhydrase inhibitors, and rho-kinase inhibitors. Combination drops that contain two active ingredients in a single bottle can simplify dosing for patients who need more than one medication. Our glaucoma specialists will discuss the benefits and potential side effects of each option with you.

After an initial diagnosis, most patients are seen every three to four months until eye pressure is stable at the target level. Once a consistent treatment regimen is established, visits typically occur every four to six months and include pressure checks, OCT imaging, and periodic visual field testing. Patients whose disease is progressing despite treatment may need more frequent appointments to adjust their care plan. Even those with childhood or congenital forms of glaucoma require lifelong monitoring, making regular follow-up a cornerstone of glaucoma management at every age.